{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:17:53Z","timestamp":1792189073571,"version":"4.4.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This study was supported by Panathera Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease, with limited treatments. Gene therapy offers an alternative strategy for treating a large portion of ALS patients, however, the disparate genetic alterations in ALS complicate the development of gene therapies. Tyrosine receptor kinase B (TRKB) and Tyro3 receptors are highly expressed in mouse spinal cord motor neurons, suggesting that their ligands, brain-derived neurotrophic factor (BDNF) and growth arrest-specific 6 (GAS6), respectively, are crucial for neuronal survival. In this study, we tested whether genetically induced and muscle tissue-specific expression of such survival-enhancing ligands would ameliorate symptom development in the SOD1\n                    <jats:sup>G93A<\/jats:sup>\n                    ALS mouse model. The therapeutic vectors (AAV-P\n                    <jats:sub>\n                      <jats:italic>mus<\/jats:italic>\n                    <\/jats:sub>\n                    7-HuBDNF-teLuc or AAV-P\n                    <jats:sub>\n                      <jats:italic>mus<\/jats:italic>\n                    <\/jats:sub>\n                    7-HuGAS6), or a control vector (AAV-P\n                    <jats:sub>\n                      <jats:italic>mus<\/jats:italic>\n                    <\/jats:sub>\n                    7-teLuc) were injected intravenously via the retro-orbital route and intramuscularly into the hindlimb skeletal muscle of six-week-old mice. Treatment with the therapeutic vectors delayed disease onset and slowed progression in both male and female mice. Interestingly, a sex-specific response was observed, with female mice benefiting more from the treatments than males. Lumbar motor neuron survival was more sustained in the therapeutic vector-treated group compared to control vector group. No statistically significant extension of lifespan was observed in the treated groups.\n                  <\/jats:p>","DOI":"10.1038\/s41434-025-00577-y","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T14:57:43Z","timestamp":1763132263000},"page":"462-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["AAV-mediated BDNF and GAS6 muscle delivery delays disease onset in SOD1G93A ALS mice"],"prefix":"10.1038","volume":"33","author":[{"given":"Yicong","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5056-4218","authenticated-orcid":false,"given":"Gongjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3988-8996","authenticated-orcid":false,"given":"Shenzhe","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialaina","family":"Nissenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Kusnecov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Furmanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond B.","family":"Birge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6985-6542","authenticated-orcid":false,"given":"Renping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"577_CR1","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: an update of recent literature. Curr Opin Neurol. 2019;32:771\u20136.","journal-title":"Curr Opin Neurol"},{"key":"577_CR2","doi-asserted-by":"crossref","unstructured":"Mesaros M, Lenz S, Lim W, Brown J, Drury L, Roggenbuck J. Investigating the genetic profile of the amyotrophic lateral sclerosis\/frontotemporal dementia (ALS-FTD) continuum in patients of diverse race, ethnicity and ancestry. Genes. 2021;13:76.","DOI":"10.3390\/genes13010076"},{"key":"577_CR3","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1001\/jamaneurol.2019.2044","volume":"76","author":"M Ryan","year":"2019","unstructured":"Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime risk and heritability of amyotrophic lateral sclerosis. JAMA Neurol. 2019;76:1367\u201374.","journal-title":"JAMA Neurol"},{"key":"577_CR4","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","volume":"88","author":"ZY Zou","year":"2017","unstructured":"Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2017;88:540\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"577_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1170996","volume":"17","author":"H Wang","year":"2023","unstructured":"Wang H, Guan L, Deng M. Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy. Front Neurosci. 2023;17:1170996.","journal-title":"Front Neurosci"},{"key":"577_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/WCO.0000000000001093","volume":"35","author":"D Brenner","year":"2022","unstructured":"Brenner D, Freischmidt A. Update on genetics of amyotrophic lateral sclerosis. Curr Opin Neurol. 2022;35:672\u20137.","journal-title":"Curr Opin Neurol"},{"key":"577_CR7","first-page":"49","volume":"6","author":"AA Alsultan","year":"2016","unstructured":"Alsultan AA, Waller R, Heath PR, Kirby J. The genetics of amyotrophic lateral sclerosis: current insights. Degener Neurol Neuromuscul Dis. 2016;6:49\u201364.","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"577_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/WCO.0000000000001294","volume":"37","author":"M Nijs","year":"2024","unstructured":"Nijs M, Van Damme P. The genetics of amyotrophic lateral sclerosis. Curr Opin Neurol. 2024;37:560\u20139.","journal-title":"Curr Opin Neurol"},{"key":"577_CR9","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1016\/j.ymthe.2021.04.008","volume":"29","author":"DA Amado","year":"2021","unstructured":"Amado DA, Davidson BL. Gene therapy for ALS: A review. Mol Ther. 2021;29:3345\u201358.","journal-title":"Mol Ther"},{"key":"577_CR10","doi-asserted-by":"publisher","first-page":"e53575","DOI":"10.1371\/journal.pone.0053575","volume":"8","author":"U Bandyopadhyay","year":"2013","unstructured":"Bandyopadhyay U, Cotney J, Nagy M, Oh S, Leng J, Mahajan M, et al. RNA-Seq profiling of spinal cord motor neurons from a presymptomatic SOD1 ALS mouse. PLoS ONE. 2013;8:e53575.","journal-title":"PLoS ONE"},{"key":"577_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/363266a0","volume":"363","author":"CE Henderson","year":"1993","unstructured":"Henderson CE, Camu W, Mettling C, Gouin A, Poulsen K, Karihaloo M, et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature. 1993;363:266\u201370.","journal-title":"Nature"},{"key":"577_CR12","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1460-9568.1993.tb00513.x","volume":"5","author":"V Wong","year":"1993","unstructured":"Wong V, Arriaga R, Ip NY, Lindsay RM. The neurotrophins BDNF, NT-3 and NT-4\/5, but not NGF, up-regulate the cholinergic phenotype of developing motor neurons. Eur J Neurosci. 1993;5:466\u201374.","journal-title":"Eur J Neurosci"},{"key":"577_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/14660820050515197","volume":"1","author":"G Ochs","year":"2000","unstructured":"Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J, et al. A phase I\/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord. 2000;1:201\u20136.","journal-title":"Amyotroph Lateral Scler Other Mot Neuron Disord"},{"key":"577_CR14","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/14660820510028412","volume":"6","author":"M Beck","year":"2005","unstructured":"Beck M, Flachenecker P, Magnus T, Giess R, Reiners K, Toyka KV, et al. Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotroph Lateral Scler Other Mot Neuron Disord. 2005;6:100\u20133.","journal-title":"Amyotroph Lateral Scler Other Mot Neuron Disord"},{"key":"577_CR15","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1212\/WNL.52.7.1427","volume":"52","author":"Group BS","year":"1999","unstructured":"Group BS. A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF Study Group (Phase III). Neurology. 1999;52:1427\u201333.","journal-title":"Neurology"},{"key":"577_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/14660820310006689","volume":"4","author":"S Kalra","year":"2003","unstructured":"Kalra S, Genge A, Arnold DL. A prospective, randomized, placebo-controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results. Amyotroph Lateral Scler Other Mot Neuron Disord. 2003;4:22\u20136.","journal-title":"Amyotroph Lateral Scler Other Mot Neuron Disord"},{"key":"577_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/01616412.2020.1834775","volume":"43","author":"J Wang","year":"2021","unstructured":"Wang J, Hu W, Feng Z, Feng M. BDNF-overexpressing human umbilical cord mesenchymal stem cell-derived motor neurons improve motor function and prolong survival in amyotrophic lateral sclerosis mice. Neurol Res. 2021;43:199\u2013209.","journal-title":"Neurol Res"},{"key":"577_CR18","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3858\/emm.2009.41.7.054","volume":"41","author":"S Park","year":"2009","unstructured":"Park S, Kim HT, Yun S, Kim IS, Lee J, Lee IS, et al. Growth factor-expressing human neural progenitor cell grafts protect motor neurons but do not ameliorate motor performance and survival in ALS mice. Exp Mol Med. 2009;41:487\u2013500.","journal-title":"Exp Mol Med"},{"key":"577_CR19","first-page":"4976","volume":"13","author":"G Manfioletti","year":"1993","unstructured":"Manfioletti G, Brancolini C, Avanzi G, Schneider C. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade. Mol Cell Biol. 1993;13:4976\u201385.","journal-title":"Mol Cell Biol"},{"key":"577_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1159\/000231894","volume":"17","author":"MD Binder","year":"2009","unstructured":"Binder MD, Kilpatrick TJ. TAM receptor signalling and demyelination. Neurosignals. 2009;17:277\u201387.","journal-title":"Neurosignals"},{"key":"577_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fmed.2018.00137","volume":"5","author":"LA Law","year":"2018","unstructured":"Law LA, Graham DK, Di Paola J, Branchford BR. GAS6\/TAM pathway signaling in hemostasis and thrombosis. Front Med. 2018;5:137.","journal-title":"Front Med"},{"key":"577_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107893","volume":"227","author":"JP Vago","year":"2021","unstructured":"Vago JP, Amaral FA, van de Loo FAJ. Resolving inflammation by TAM receptor activation. Pharm Ther. 2021;227:107893.","journal-title":"Pharm Ther"},{"key":"577_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0769-1","volume":"17","author":"G Wu","year":"2018","unstructured":"Wu G, Ma Z, Cheng Y, Hu W, Deng C, Jiang S, et al. Targeting Gas6\/TAM in cancer cells and tumor microenvironment. Mol Cancer. 2018;17:20.","journal-title":"Mol Cancer"},{"key":"577_CR24","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/S0006-8993(98)01159-7","volume":"816","author":"AL Prieto","year":"1999","unstructured":"Prieto AL, Weber JL, Tracy S, Heeb MJ, Lai C. Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system. Brain Res. 1999;816:646\u201361.","journal-title":"Brain Res"},{"key":"577_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/jnr.10211","volume":"68","author":"H Funakoshi","year":"2002","unstructured":"Funakoshi H, Yonemasu T, Nakano T, Matumoto K, Nakamura T. Identification of Gas6, a putative ligand for Sky and Axl receptor tyrosine kinases, as a novel neurotrophic factor for hippocampal neurons. J Neurosci Res. 2002;68:150\u201360.","journal-title":"J Neurosci Res"},{"key":"577_CR26","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/S0028-3908(02)00333-7","volume":"43","author":"T Yagami","year":"2002","unstructured":"Yagami T, Ueda K, Asakura K, Sakaeda T, Nakazato H, Kuroda T, et al. Gas6 rescues cortical neurons from amyloid beta protein-induced apoptosis. Neuropharmacology. 2002;43:1289\u201396.","journal-title":"Neuropharmacology"},{"key":"577_CR27","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1523\/JNEUROSCI.16-06-02012.1996","volume":"16","author":"R Li","year":"1996","unstructured":"Li R, Chen J, Hammonds G, Phillips H, Armanini M, Wood P, et al. Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci. 1996;16:2012\u20139.","journal-title":"J Neurosci"},{"key":"577_CR28","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.1523\/JNEUROSCI.23-10-04208.2003","volume":"23","author":"SL Shankar","year":"2003","unstructured":"Shankar SL, O\u2019Guin K, Cammer M, McMorris FA, Stitt TN, Basch RS, et al. The growth arrest-specific gene product Gas6 promotes the survival of human oligodendrocytes via a phosphatidylinositol 3-kinase-dependent pathway. J Neurosci. 2003;23:4208\u201318.","journal-title":"J Neurosci"},{"key":"577_CR29","doi-asserted-by":"publisher","first-page":"e17727","DOI":"10.1371\/journal.pone.0017727","volume":"6","author":"MD Binder","year":"2011","unstructured":"Binder MD, Xiao J, Kemper D, Ma GZ, Murray SS, Kilpatrick TJ. Gas6 increases myelination by oligodendrocytes and its deficiency delays recovery following cuprizone-induced demyelination. PLoS ONE. 2011;6:e17727.","journal-title":"PLoS ONE"},{"key":"577_CR30","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s12975-024-01246-9","volume":"15","author":"J Tang","year":"2024","unstructured":"Tang J, Jin Y, Jia F, Lv T, Manaenko A, Zhang LF, et al. Correction to: Gas6 promotes microglia efferocytosis and suppresses inflammation through activating Axl\/Rac1 signaling in subarachnoid hemorrhage mice. Transl Stroke Res. 2024;15:859\u201360.","journal-title":"Transl Stroke Res"},{"key":"577_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/0271678X231205078","volume":"44","author":"J Jia","year":"2024","unstructured":"Jia J, Xu S, Hu J, Gan Y, Sun M, Xia S, et al. Growth arrest specific protein 6 alleviated white matter injury after experimental ischemic stroke. J Cereb Blood Flow Metab. 2024;44:77\u201393.","journal-title":"J Cereb Blood Flow Metab"},{"key":"577_CR32","doi-asserted-by":"publisher","first-page":"e15748","DOI":"10.1371\/journal.pone.0015748","volume":"5","author":"V Tsiperson","year":"2010","unstructured":"Tsiperson V, Li X, Schwartz GJ, Raine CS, Shafit-Zagardo B. GAS6 enhances repair following cuprizone-induced demyelination. PLoS ONE. 2010;5:e15748.","journal-title":"PLoS ONE"},{"key":"577_CR33","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/gt.2008.104","volume":"15","author":"B Wang","year":"2008","unstructured":"Wang B, Li J, Fu FH, Chen C, Zhu X, Zhou L, et al. Construction and analysis of compact muscle-specific promoters for AAV vectors. Gene Ther. 2008;15:1489\u201399.","journal-title":"Gene Ther"},{"key":"577_CR34","doi-asserted-by":"publisher","first-page":"5058","DOI":"10.1128\/MCB.16.9.5058","volume":"16","author":"MA Shield","year":"1996","unstructured":"Shield MA, Haugen HS, Clegg CH, Hauschka SD. E-box sites and a proximal regulatory region of the muscle creatine kinase gene differentially regulate expression in diverse skeletal muscles and cardiac muscle of transgenic mice. Mol Cell Biol. 1996;16:5058\u201368.","journal-title":"Mol Cell Biol"},{"key":"577_CR35","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.1128\/AEM.01466-14","volume":"80","author":"ML Burns","year":"2014","unstructured":"Burns ML, Malott TM, Metcalf KJ, Hackel BJ, Chan JR, Shusta EV. Directed evolution of brain-derived neurotrophic factor for improved folding and expression in Saccharomyces cerevisiae. Appl Environ Microbiol. 2014;80:5732\u201342.","journal-title":"Appl Environ Microbiol"},{"key":"577_CR36","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nmeth.4400","volume":"14","author":"HW Yeh","year":"2017","unstructured":"Yeh HW, Karmach O, Ji A, Carter D, Martins-Green MM, Ai HW. Red-shifted luciferase-luciferin pairs for enhanced bioluminescence imaging. Nat Methods. 2017;14:971\u20134.","journal-title":"Nat Methods"},{"key":"577_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08283-7","volume":"10","author":"S Sarcar","year":"2019","unstructured":"Sarcar S, Tulalamba W, Rincon MY, Tipanee J, Pham HQ, Evens H, et al. Next-generation muscle-directed gene therapy by in silico vector design. Nat Commun. 2019;10:492.","journal-title":"Nat Commun"},{"key":"577_CR38","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1038\/nn.4593","volume":"20","author":"KY Chan","year":"2017","unstructured":"Chan KY, Jang MJ, Yoo BB, Greenbaum A, Ravi N, Wu WL, et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci. 2017;20:1172\u20139.","journal-title":"Nat Neurosci"},{"key":"577_CR39","doi-asserted-by":"publisher","unstructured":"Richner M, Jager SB, Siupka P, Vaegter CB. Hydraulic extrusion of the spinal cord and isolation of dorsal root ganglia in rodents. J Vis Exp. 2017;5226. https:\/\/doi.org\/10.3791\/55226.","DOI":"10.3791\/55226"},{"key":"577_CR40","doi-asserted-by":"publisher","unstructured":"Hatzipetros T, Kidd JD, Moreno AJ, Thompson K, Gill A, Vieira FG. A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS. J Vis Exp. 2015;53257. https:\/\/doi.org\/10.3791\/53257.","DOI":"10.3791\/53257"},{"key":"577_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1238453","volume":"16","author":"WM Stansberry","year":"2023","unstructured":"Stansberry WM, Pierchala BA. Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis. Front Mol Neurosci. 2023;16:1238453.","journal-title":"Front Mol Neurosci"},{"key":"577_CR42","first-page":"46","volume":"01","author":"Y Le","year":"2023","unstructured":"Le Y, Jiang Z, Zheng X, Marinaro C, Chen S, Wang B, et al. An AAV vector for inducible gene expression preferentially in muscles. Int J Genet Modif Recomb. 2023;01:46\u201361.","journal-title":"Int J Genet Modif Recomb"},{"key":"577_CR43","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27:1918\u201329.","journal-title":"Eur J Neurol"},{"key":"577_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-7571-6_1","volume":"1727","author":"SD Skaper","year":"2018","unstructured":"Skaper SD. Neurotrophic factors: an overview. Methods Mol Biol. 2018;1727:1\u201317.","journal-title":"Methods Mol Biol"},{"key":"577_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fnagi.2017.00068","volume":"9","author":"D Petrov","year":"2017","unstructured":"Petrov D, Mansfield C, Moussy A, Hermine O. ALS clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?. Front Aging Neurosci. 2017;9:68.","journal-title":"Front Aging Neurosci"},{"key":"577_CR46","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s41591-022-01956-3","volume":"28","author":"RH Baloh","year":"2022","unstructured":"Baloh RH, Johnson JP, Avalos P, Allred P, Svendsen S, Gowing G, et al. Transplantation of human neural progenitor cells secreting GDNF into the spinal cord of patients with ALS: a phase 1\/2a trial. Nat Med. 2022;28:1813\u201322.","journal-title":"Nat Med"},{"key":"577_CR47","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.1086137","volume":"301","author":"BK Kaspar","year":"2003","unstructured":"Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science. 2003;301:839\u201342.","journal-title":"Science"},{"key":"577_CR48","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1179\/016164105X39860","volume":"27","author":"I Nagano","year":"2005","unstructured":"Nagano I, Shiote M, Murakami T, Kamada H, Hamakawa Y, Matsubara E, et al. Beneficial effects of intrathecal IGF-1 administration in patients with amyotrophic lateral sclerosis. Neurol Res. 2005;27:768\u201372.","journal-title":"Neurol Res"},{"key":"577_CR49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.expneurol.2006.08.028","volume":"203","author":"W Li","year":"2007","unstructured":"Li W, Brakefield D, Pan Y, Hunter D, Myckatyn TM, Parsadanian A. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp Neurol. 2007;203:457\u201371.","journal-title":"Exp Neurol"},{"key":"577_CR50","doi-asserted-by":"publisher","first-page":"6920","DOI":"10.1523\/JNEUROSCI.22-16-06920.2002","volume":"22","author":"LJ Wang","year":"2002","unstructured":"Wang LJ, Lu YY, Muramatsu S, Ikeguchi K, Fujimoto K, Okada T, et al. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci. 2002;22:6920\u20138.","journal-title":"J Neurosci"},{"key":"577_CR51","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1080\/17482960600982447","volume":"8","author":"M Suzuki","year":"2007","unstructured":"Suzuki M, Tork C, Shelley B, McHugh J, Wallace K, Klein SM, et al. Sexual dimorphism in disease onset and progression of a rat model of ALS. Amyotroph Lateral Scler. 2007;8:20\u20135.","journal-title":"Amyotroph Lateral Scler"},{"key":"577_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2005.02.006","volume":"236","author":"TD Heiman-Patterson","year":"2005","unstructured":"Heiman-Patterson TD, Deitch JS, Blankenhorn EP, Erwin KL, Perreault MJ, Alexander BK, et al. Background and gender effects on survival in the TgN(SOD1-G93A)1Gur mouse model of ALS. J Neurol Sci. 2005;236:1\u20137.","journal-title":"J Neurol Sci"},{"key":"577_CR53","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0960-8966(03)00104-4","volume":"13","author":"JH Veldink","year":"2003","unstructured":"Veldink JH, Bar PR, Joosten EA, Otten M, Wokke JH, van den Berg LH. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul Disord. 2003;13:737\u201343.","journal-title":"Neuromuscul Disord"},{"key":"577_CR54","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.brainres.2007.09.034","volume":"1185","author":"AC Lepore","year":"2007","unstructured":"Lepore AC, Haenggeli C, Gasmi M, Bishop KM, Bartus RT, Maragakis NJ, et al. Intraparenchymal spinal cord delivery of adeno-associated virus IGF-1 is protective in the SOD1G93A model of ALS. Brain Res. 2007;1185:256\u201365.","journal-title":"Brain Res"},{"key":"577_CR55","doi-asserted-by":"publisher","first-page":"6831","DOI":"10.1167\/iovs.16-20074","volume":"57","author":"VM Harandi","year":"2016","unstructured":"Harandi VM, Gaied AR, Brannstrom T, Pedrosa Domellof F, Liu JX. Unchanged Neurotrophic Factors and Their Receptors Correlate With Sparing in Extraocular Muscles in Amyotrophic Lateral Sclerosis. Investig Ophthalmol Vis Sci. 2016;57:6831\u201342.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"577_CR56","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1007\/s00018-019-03337-5","volume":"77","author":"L Just-Borras","year":"2020","unstructured":"Just-Borras L, Hurtado E, Cilleros-Mane V, Biondi O, Charbonnier F, Tomas M, et al. Running and swimming prevent the deregulation of the BDNF\/TrkB neurotrophic signalling at the neuromuscular junction in mice with amyotrophic lateral sclerosis. Cell Mol Life Sci. 2020;77:3027\u201340.","journal-title":"Cell Mol Life Sci"},{"key":"577_CR57","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1006\/exnr.2002.8011","volume":"177","author":"BM Kust","year":"2002","unstructured":"Kust BM, Copray JC, Brouwer N, Troost D, Boddeke HW. Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp Neurol. 2002;177:419\u201327.","journal-title":"Exp Neurol"},{"key":"577_CR58","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1097\/00005072-199809000-00003","volume":"57","author":"Y Kawamoto","year":"1998","unstructured":"Kawamoto Y, Nakamura S, Akiguchi I, Kimura J. Immunohistochemical localization of brain-derived neurotrophic factor in the spinal cords of amyotrophic lateral sclerosis and non-amyotrophic lateral sclerosis patients. J Neuropathol Exp Neurol. 1998;57:822\u201330.","journal-title":"J Neuropathol Exp Neurol"},{"key":"577_CR59","doi-asserted-by":"crossref","unstructured":"Riolo G, Ricci C, De Angelis N, Marzocchi C, Guerrera G, Borsellino G, et al. BDNF and Pro-BDNF in amyotrophic lateral sclerosis: a new perspective for biomarkers of neurodegeneration. Brain Sci. 2022;12:617.","DOI":"10.3390\/brainsci12050617"},{"key":"577_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02730-1","volume":"22","author":"MC Cao","year":"2022","unstructured":"Cao MC, Cawston EE, Chen G, Brooks C, Douwes J, McLean D, et al. Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis. BMC Neurol. 2022;22:216.","journal-title":"BMC Neurol"},{"key":"577_CR61","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000445110","volume":"75","author":"L Tremolizzo","year":"2016","unstructured":"Tremolizzo L, Pellegrini A, Susani E, Lunetta C, Woolley SC, Ferrarese C, et al. Behavioural but not cognitive impairment is a determinant of caregiver burden in amyotrophic lateral sclerosis. Eur Neurol. 2016;75:191\u20134.","journal-title":"Eur Neurol"},{"key":"577_CR62","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1023\/A:1007575504321","volume":"25","author":"T Mutoh","year":"2000","unstructured":"Mutoh T, Sobue G, Hamano T, Kuriyama M, Hirayama M, Yamamoto M, et al. Decreased phosphorylation levels of TrkB neurotrophin receptor in the spinal cords from patients with amyotrophic lateral sclerosis. Neurochem Res. 2000;25:239\u201345.","journal-title":"Neurochem Res"},{"key":"577_CR63","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s13311-021-01025-6","volume":"18","author":"G Modol-Caballero","year":"2021","unstructured":"Modol-Caballero G, Garcia-Lareu B, Herrando-Grabulosa M, Verdes S, Lopez-Vales R, Pages G, et al. Specific expression of glial-derived neurotrophic factor in muscles as gene therapy strategy for amyotrophic lateral sclerosis. Neurotherapeutics. 2021;18:1113\u201326.","journal-title":"Neurotherapeutics"},{"key":"577_CR64","doi-asserted-by":"publisher","first-page":"e20881","DOI":"10.1371\/journal.pone.0020881","volume":"6","author":"A Leger","year":"2011","unstructured":"Leger A, Le Guiner C, Nickerson ML, McGee Im K, Ferry N, Moullier P, et al. Adeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscle. PLoS ONE. 2011;6:e20881.","journal-title":"PLoS ONE"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00577-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00577-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T09:02:26Z","timestamp":1786611746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-025-00577-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1038\/s41434-025-00577-y","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experimental procedures were conducted in accordance with the guidelines from the Office of Research any approved by the IACUC of Rutgers, the State University of New Jersey (PROC00050848).","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}